![A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models: Molecular Therapy A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models: Molecular Therapy](https://www.cell.com/cms/attachment/71e0677c-57e3-4f48-8ebf-b42c74b8c848/fx1_lrg.jpg)
A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models: Molecular Therapy
![Q and A with the experts: Busting common myths about mRNA vaccines | Waterloo News | University of Waterloo Q and A with the experts: Busting common myths about mRNA vaccines | Waterloo News | University of Waterloo](https://uwaterloo.ca/news/sites/ca.news/files/resize/mrna-vaccine-myths-7-500x647.png)
Q and A with the experts: Busting common myths about mRNA vaccines | Waterloo News | University of Waterloo
![COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18, 2022–August 21, 2022 | MMWR COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18, 2022–August 21, 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7135a3_VaxSafetyForChildren_IMAGE_02Sep2022_1200x675_1-medium.jpg?_=57539)
COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18, 2022–August 21, 2022 | MMWR
![Frontiers | How far are the new wave of mRNA drugs from us? mRNA product current perspective and future development Frontiers | How far are the new wave of mRNA drugs from us? mRNA product current perspective and future development](https://www.frontiersin.org/files/Articles/974433/fimmu-13-974433-HTML-r1/image_m/fimmu-13-974433-g001.jpg)
Frontiers | How far are the new wave of mRNA drugs from us? mRNA product current perspective and future development
Pennsylvania Department of Health - #COVID19 vaccines currently authorized for use in the US don't use the live virus that causes COVID-19 and cannot give you COVID-19. Having symptoms like fever after
![Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors - The Lancet Oncology Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors - The Lancet Oncology](https://www.thelancet.com/cms/attachment/1b50e54c-826f-483e-99ae-7498698cfd92/gr1_lrg.jpg)
Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors - The Lancet Oncology
![IJMS | Free Full-Text | Concern about the Effectiveness of mRNA Vaccination Technology and Its Long-Term Safety: Potential Interference on miRNA Machinery IJMS | Free Full-Text | Concern about the Effectiveness of mRNA Vaccination Technology and Its Long-Term Safety: Potential Interference on miRNA Machinery](https://www.mdpi.com/ijms/ijms-24-01404/article_deploy/html/images/ijms-24-01404-g001.png)
IJMS | Free Full-Text | Concern about the Effectiveness of mRNA Vaccination Technology and Its Long-Term Safety: Potential Interference on miRNA Machinery
![Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina - The Lancet Regional Health – Americas Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina - The Lancet Regional Health – Americas](https://www.thelancet.com/cms/asset/394c7d04-633c-4b1b-a67a-51279311d368/gr1.jpg)